Larry Miller

Chief Operating Officer, PHIBRO ANIMAL HEALTH CORP

Search every verified Larry Miller interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a September 2019 interview at VIV ASIA, Larry Miller, Chief Operating Officer of Phibro Animal Health, discussed the company's operations and product offerings. He stated that the company is "very heavily involved in the Asia-Pacific region" and operates globally in major livestock markets. Miller described the company's products as including medicated feed additives, nutrition specialty products for immune function and intestinal health, and a range of vaccines. He noted that the company services poultry, swine, aquaculture, and beef and dairy cattle. Miller highlighted several products featured at the event, including a new vaccine called MB1 for day-of-age chicks, an IB variant vaccine, and AVX Plus for controlling coccidiosis in poultry. He also mentioned Magnifide, a blend of natural products for enhancing immunity and gut health in broiler chickens. Miller said the company's customers include distributor customers and large livestock producers, and that the event provided an opportunity to align plans for growth with them. He added that the company aims to understand customers' unique challenges and bring solutions to address them.